NCT06585007
- Conditions
- Castration-resistant Prostate Cancer, Oligoprogressive
- Locations
-
- University Hospitals Leuven Leuven, Belgium
Clinical trial condition
Castration-resistant Prostate Cancer
Explore clinical trials studying Castration-resistant Prostate Cancer. Study availability and eligibility vary by location and protocol.
65 public trials
14 recruiting studies
Castration-resistant Prostate Cancer trial results
NCT06343038
- Conditions
- Castration-resistant Prostate Cancer
- Locations
-
- University Hospital Basel Basel, Switzerland
NCT04838899
- Conditions
- Castration-resistant Prostate Cancer, Oligoprogressive
- Locations
-
- Odette Cancer Centre Toronto, Ontario, Canada
NCT06321679
- Conditions
- Castration-resistant Prostate Cancer
- Locations
-
- IEO Istituto Europeo di Oncologia Milan, Italy
Not yet recruiting
A Study of BL-B01D1 Combination Therapy in Patients With Metastatic Castration-resistant Prostate Cancer
NCT07641855
- Conditions
- Castration-resistant Prostate Cancer
- Locations
-
- The First Medical Center of Chinese PLA General Hospital Beijing, Beijing Municipality, China
- The First Affiliated Hospital of Naval Medical University (Shanghai Changhai Hospital) Shanghai, Shanghai Municipality, China
Active, not recruiting
Study of Cabozantinib and Nivolumab in Metastatic Castration Resistant Prostate Cancer
NCT05502315
- Conditions
- Castration-resistant Prostate Cancer, Metastatic Cancer, Neoplasm Metastasis, +4 more
- Locations
-
- University of California San Diego La Jolla, California, United States
- University of Chicago Medical Center Chicago, Illinois, United States
- University of Texas Southwestern Medical Center Dallas, Texas, United States
- University of Wisconsin Madison, Wisconsin, United States
Active, not recruiting
pTVG-HP DNA Vaccine With or Without pTVG-AR DNA Vaccine and Pembrolizumab in Patients With Castration-Resistant, Metastatic Prostate Cancer
NCT04090528
- Conditions
- Bulbo-Spinal Atrophy, X-Linked, Castration-resistant Prostate Cancer, Central Nervous System Diseases, +26 more
- Locations
-
- Washington University Siteman Cancer Center St Louis, Missouri, United States
- University of Wisconsin Carbone Cancer Center Madison, Wisconsin, United States
Active, not recruiting
Clinical Study of Safety and Efficacy of Universal PSMA CAR- T in Refractory CRPC
NCT06895811
- Conditions
- Castration-resistant Prostate Cancer, Genital Diseases, Genital Diseases, Male, +10 more
- Locations
-
- Changzheng hospital Shanghai, Shanghai Municipality, China
Active, not recruiting
Clinical Study of Safety and Efficacy of Enhanced PSMA CAR- T in Refractory CRPC
NCT06228404
- Conditions
- Castration-resistant Prostate Cancer, Metastatic Castration-resistant Prostate Cancer, Neoplasm Metastasis, +4 more
- Locations
-
- Changzheng hospital Shanghai, Shanghai Municipality, China
Active, not recruiting
Comparing Continuation or De-escalation of Bone Modifying Agents (BMA) in Patients Treated for Over 2 Years for Bone Metastases From Either Breast or Castration-resistant Prostate Cancer
NCT04549207
- Conditions
- Breast Cancer, Breast Diseases, Breast Neoplasms, +5 more
- Locations
-
- William Osler Health System Brampton, Ontario, Canada
- London Health Sciences Centre London, Ontario, Canada
- Southlake Regional Health Centre Newmarket, Ontario, Canada
- The Ottawa Hospital Cancer Centre Ottawa, Ontario, Canada